首页> 外文期刊>The American Surgeon >A Prospective Randomized Pilot Study of Near-Infrared Spectroscopy-Directed Restricted Fluid Therapy versus Standard Fluid Therapy in Patients Undergoing Elective Colorectal Surgery
【24h】

A Prospective Randomized Pilot Study of Near-Infrared Spectroscopy-Directed Restricted Fluid Therapy versus Standard Fluid Therapy in Patients Undergoing Elective Colorectal Surgery

机译:择期结直肠手术患者近红外光谱定向限制性液体疗法与标准液体疗法的前瞻性随机先导研究

获取原文
获取原文并翻译 | 示例
           

摘要

There are substantial data supporting the concept that algorithms that effectively limit fluid volumes to patients undergoing elective surgery, particularly intraoperatively, significantly reduce perioperative morbidity. We hypothesized that intraoperative fluid limitation could be safely accomplished when guided by near-infrared spectroscopy (NIRS) monitoring, and that this fluid restriction regimen would result in a reduction in postoperative morbidity when compared with standard monitoring and fluid therapy. The intent of this pilot study was to demonstrate the feasibility and ease of conduct of this study protocol before expanding to the multicenter pivotal trial. We performed a prospective, (2:1) randomized, pilot study at two centers. A total enrollment of 24 fully evaluable patients undergoing elective open colorectal surgery (16 restricted, 8 standard) was planned. After providing informed consent, patients were randomized to standard fluid resuscitation (500 LR induction bolus, then LR 7 mL/kg/h × 1 h, then 5 mL/kg/h) or restricted fluid resuscitation (no induction bolus, then LR 2 mL/kg/h). Subsequent fluid bolus infusions were guided by physiologic parameters (systolic blood pressure 100 bpm, or oliguria) in the standard group, and by tissue oxygen saturation from NIRS (tissue oxygen saturation (StO^sub 2^) < 75%, or 20% below baseline; or the same physiologic parameters) in the restricted group. Primary endpoints were major postoperative complications. A total of 27 patients were randomized (18 restricted, 9 standard). Age, gender, ethnicity, past medical history, and body mass index were similar. American Society of Anesthesiologists class was somewhat higher in the restricted group (American Society of Anesthesiologists class 3 in 77% of restricted vs 44% of standard patients; P = 0.194). Median total intraoperative fluids were less in the restricted group (1300 mL) when compared with the standard group (3014 mL) (P = 0.021). Total fluids for the hospitalization were also statistically significantly decreased in the restricted group. Complications occurred in about two-thirds of patients, and complication rates were not statistically different between groups (1.6/restricted patient vs 2.1/standard patient; P = 0.333). Primary indications for boluses (n = 93) given to study patients were: hypotension (69%); oliguria (15%); and tachycardia (14%), with multiple indications per bolus. In only two instances did the StO^sub 2^ drop to less than 75 per cent, or decrease by 20 per cent from baseline in the 3 minutes before bolus as an indication for fluid administration. Patients undergoing elective colorectal surgery with a fluid restricted strategy had only rare episodes of decreased StO^sub 2^, suggesting that adequate tissue perfusion was maintained in this group. As a result, NIRS monitoring did not significantly influence intraoperative fluid management of patients undergoing colorectal surgery. [PUBLICATION ABSTRACT]
机译:有大量数据支持这一观点,即有效地限制选择性外科手术患者(尤其是术中患者)的输液量的算法可显着降低围手术期发病率。我们假设在近红外光谱(NIRS)监测的指导下可以安全地完成术中液体限制,并且与标准监测和液体治疗相比,这种液体限制方案将降低术后发病率。这项初步研究的目的是证明在扩展至多中心枢纽试验之前,该研究方案的可行性和操作简便性。我们在两个中心进行了一项前瞻性(2:1)随机先导研究。计划总共招募24名接受选择性开放性结直肠手术的完全可评估患者(16例受限,8例标准)。提供知情同意后,患者被随机分为标准液体复苏(500 LR诱导推注,然后LR 7 mL / kg / h×1 h,然后5 mL / kg / h)或限制性液体复苏(无诱导推注,然后LR 2)。 mL / kg / h)。标准组的生理参数(收缩压100 bpm或少尿)和NIRS的组织氧饱和度(组织氧饱和度(StO ^ sub 2 ^)<75%或低于20%)指导后续的液体推注基线;或相同的生理参数)。主要终点是术后主要并发症。总共27例患者被随机分组​​(18例受限,9例标准)。年龄,性别,种族,既往病史和体重指数相似。在限制组中,美国麻醉医师学会等级较高(美国麻醉医师学会等级3为77%受限制患者,相对于标准患者为44%; P = 0.194)。与标准组(3014 mL)相比,限制组(1300 mL)的术中总中位数较少(P = 0.021)。在限制组中,用于住院的总体液也有统计学显着下降。并发症发生在大约三分之二的患者中,两组之间的并发症发生率在统计学上没有差异(1.6 /限制性患者与2.1 /标准患者; P = 0.333)。研究患者给予大剂量的主要适应症(n = 93)为:低血压(69%);少尿(15%);心动过速(14%),每次推注有多种适应症。在仅两次情况下,在推注前3分钟内,StOsub 2 ^降至低于75%,或从基线降低了20%,以作为输注液体的指标。采取液体限制策略进行选择性大肠直肠癌手术的患者仅出现罕见的StO ^ sub 2 ^降低事件,这表明该组患者维持了足够的组织灌注。结果,NIRS监测并没有显着影响接受结直肠手术的患者的术中液体管理。 [出版物摘要]

著录项

  • 来源
    《The American Surgeon》 |2010年第12期|p.1384-1392|共9页
  • 作者单位

    STEPHEN M. COHN, M.D.,* RONALD G. PEARL, M.D.,+ SHIRLEY M. ACOSTA, R.N., B.S.N.,* MARILYN U. NOWLIN, R.N.,[double dagger] ANTONIO HERNANDEZ, M.D.,* COSMIN GUTA, M.D.,[dagger] JOEL E. MICHALEK, Ph.D.,* THE NIRF CLINICAL TRIALS GROUPFrom the * Department of Surgery, University of Texas Health Science Center, San Antonio, Texas, [dagger] Stanford University, Stanford, California, and [double dagger] Brooke Army Medical Center, San Antonio, TexasAddress correspondence and reprint requests to Stephen M. Cohn, M.D., Department of Surgery, University of Texas Health Science Center, 7703 Floyd Curi Drive, San Antonio, TX 78229. E-mail: cohn@uthscsa.edu.,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号